Service Area: United States and Europe
About
AdvancedBio Consulting provides nonclinical, scientific development and regulatory strategy to academic institutions and early- and late-stage biotechnology and pharmaceutical companies seeking to develop advanced regenerative medicine products. These include cell and gene therapies, small molecules, and combination products targeting the US (FDA) and European (EMA) commercial markets. We help clients to resolve complex regulatory agency feedback to advance product success.
Company Mission
To define and refine nonclinical testing and biocompatibility strategies for biologics, small molecules, and combination products (including delivery devices and novel delivery platforms) in compliance with region- and division-specific regulatory requirements.